comparemela.com

Page 13 - Nasdaq Holx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IQ EQ FUND MANAGEMENT IRELAND Ltd Has $2 22 Million Stock Position in Hologic, Inc (NASDAQ:HOLX)

IQ EQ FUND MANAGEMENT IRELAND Ltd reduced its stake in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 4.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 31,950 shares of the medical equipment provider’s stock after selling 1,426 shares during the […]

Argus Investors Counsel Inc Boosts Position in Hologic, Inc (NASDAQ:HOLX)

Argus Investors Counsel Inc. raised its stake in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 4.8% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,875 shares of the medical equipment provider’s stock after buying an additional 549 shares during the quarter. […]

Kentucky Retirement Systems Takes $1 41 Million Position in Hologic, Inc (NASDAQ:HOLX)

Kentucky Retirement Systems purchased a new position in Hologic, Inc. (NASDAQ:HOLX – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 20,285 shares of the medical equipment provider’s stock, valued at approximately $1,408,000. A number of other institutional investors and […]

Hologic, Inc (NASDAQ:HOLX) Given Consensus Rating of Moderate Buy by Brokerages

Shares of Hologic, Inc. (NASDAQ:HOLX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the thirteen brokerages that are currently covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month […]

Hologic, Inc (NASDAQ:HOLX) Receives $86 58 Average Price Target from Brokerages

Hologic, Inc. (NASDAQ:HOLX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the thirteen research firms that are covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year price […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.